期刊文献+

复方醋酸环丙孕酮联合二甲双胍治疗多囊卵巢综合征的效果分析 被引量:2

Analysis of the effect of Compound Cyproterone Acetate combined with metformin on the endocrine of polycystic ovary syndrome
下载PDF
导出
摘要 目的:探讨使用复方醋酸环丙孕酮联合二甲双胍治疗多囊卵巢综合征的效果。方法:选取2017年1月至2017年11月期间四川省人民医院收治的56例多囊卵巢综合征患者作为研究对象。随机将这些患者分为对照组(n=28)和观察组(n=28)。为对照组患者使用复方醋酸环丙孕酮进行治疗,为观察组患者使用复方醋酸环丙孕酮联合二甲双胍进行治疗。然后比较两组患者血清甘油三酯(TG)、高密度脂蛋白(HDL-C)、低密度脂蛋白(LDL-C)、总胆固醇(TC)、空腹血糖(FPG)、空腹胰岛素(FINS)、卵泡刺激素(FSH)、血清黄体生成素(LH)、睾酮(T)、雌二醇(E2)、性激素结合球蛋白(SHBG)的水平。结果:治疗后,观察组患者TG、LDL-C、LH/FSL、T及E2的水平均低于对照组患者(P<0.05),其HDL-C及SHBG的水平均高于对照组患者(P<0.05)。结论:使用复方醋酸环丙孕酮联合二甲双胍治疗多囊卵巢综合征可调节患者生殖激素及血脂的水平,改善其胰岛素抵抗的情况。 Objective :To investigate the effect of compound cyclopropanone acetate combined with metformin on the endocrine of polycystic ovary syndrome(PCOS).Method :56 cases of PCOS patients in the hospital were randomly divided into two groups,control group and experimental group, the control group was given the compound cyclopropanone acetate, and the observation group was given metformin and compound cyclopropanone acetate. Then compare levels of TG,HDL-C,LDLC,TC,FPG,FINS,FSH,LH,T,E2,SHBG of 2 groups.Result :After treatment, levels of TG,LDL-C,LH/FSL,T and E2 of experimental group are lower than that in control group(P〈0.05), levels of HDL-C and SHBG of experimental group than that in control group(P〈0.05).Conclusion :The effect of compound cyclopropanone acetate combined with metformin on the endocrine of polycystic ovary syndrome are regulating levels of reproductive hormone and blood lipid, and improving insulin resistant.
作者 夏一丹
出处 《当代医药论丛》 2017年第22期163-164,共2页
关键词 复方醋酸环丙孕酮 二甲双胍 多囊卵巢综合征 Compound cyclopropanone acetate, metformin, polycystic ovary syndrome
  • 相关文献

参考文献5

二级参考文献41

  • 1王琦,叶加农,朱燕波,高京宏,董静,王东坡,吴宏东.中医痰湿体质的判定标准研究[J].中华中医药杂志,2006,21(2):73-75. 被引量:150
  • 2何淑明,邢福祺.左旋炔诺酮宫内缓释系统对子宫疾病的治疗作用[J].海南医学,2006,17(4):127-128. 被引量:17
  • 3邓姗,郎景和,冷金花,刘珠凤,孙大为,朱兰.曼月乐对子宫内膜异位症患者在位内膜增殖与凋亡的影响[J].生殖与避孕,2006,26(10):589-592. 被引量:114
  • 4刑海燕.多囊卵巢综合症的内分泌代谢紊乱及胰岛素增敏剂治疗的效果观察[J].山东大学,2009,5(17):1-21.
  • 5Knochenhauer E S, Key T J, Kahsar-Miller M,et al. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab, 1998,83 ( 9 ) :3078-3082.
  • 6Diamanti- Kandarakis E, Kouli C R, Bergiele AT, et al. A survey of the polycysticovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab, 1999,84 ( 11 ) :4006-4011.
  • 7Asuncion M, Calvo R M, San Millan JL, et al. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab, 2000,85 (7) :2434-2438.
  • 8Azziz R, Woods K S, Reyna R, et al. The prevalence and features of the polyeystie ovary syndrome in an unseleeted population. J Clin Endocrinol Metab, 2004,89(6) :2745-2749.
  • 9Goodarzi M O, Dumesic D A, Chazenbalk Get al. Polycystic ovary syndrome : etiology, pathogenesis and diagnosis. Nat Rev Endocrinol, 2011 ,7 (4) :219-231.
  • 10Lungu A O, Zadeh E S, Goodling A, et al. Insulin resistance is a sufficient basis for hyperandmgenism in lipodystrophic women with polycystic ovariansyndrome. J Clin Endocrinol Metab, 2012, 97 (2) :563-567.

共引文献39

同被引文献14

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部